Mutations in the depalmitoylation enzyme, palmitoyl protein thioesterase (PPT1), result in the early onset neurodegenerative disease known as Infantile Neuronal Ceroid Lipofuscinosis. Here, we provide proteomic evidence suggesting that PPT1 deficiency could be considered as a ciliopathy. Analysis of membrane proteins from brain enriched for acylated proteins from neonate Ppt1 knock out and control mice revealed a list of 88 proteins with differential expression levels. Amongst them, we identified Rab3IP, which regulates ciliogenesis in concert with Rab8 and Rab11. Immunostaining analysis revealed that PPT1 is localized in the cilia. Indeed, an unbiased proteomics analysis on isolated cilia revealed 660 proteins, which differed in their abundance levels between wild type and Ppt1 knock out. We demonstrate here that Rab3IP, Rab8 and Rab11 are palmitoylated, and that palmitoylation of Rab11 is required for correct intracellular localization. Cells and brain preparations from Ppt1-/-mice exhibited fewer cells with cilia and abnormally longer cilia, with both acetylated tubulin and Rab3IP wrongly distributed along the length of cilia. Most importantly, the analysis revealed a difference in the distribution and levels of the modified proteins in cilia in the retina of mutant mice versus the wildtype, which may be important in the early neurodegenerative phenotype. Overall, our results suggest a novel link between palmitoylated proteins, cilial organization and the pathophysiology of Neuronal Ceroid Lipofuscinosis.
Introduction
Neuronal Ceroid Lipofuscinosis (NCL) represents a group of common progressive encephalopathies of children (1, 2) . These disorders have an incidence of as high as one in 12,500 births and are more common in Northern Europe than in other locations (1) . The pathological hallmark of the NCLs is the accumulation of auto-fluorescent storage material in the brain and other tissues, associated with progressive psychomotor retardation, visual failure, and seizures. Mutations in eight different genes have been identified as causative of this disease. Mutations in the CLN1 gene, which encodes for the palmitoyl protein thioesterase (PPT1) enzyme cause the infantile form of this disease (OMIM #256730) (3) . Mutations in the same gene may also result in the less severe juvenile form of this disease (4) . PPT1 is a lysosomal thio-esterase the function of which is to remove long-chain fatty acids from modified cysteine residues in proteins (5) . The addition of long-chain fatty acids to cysteine residues is also known as S-acylation and since the fatty acid palmitate is most often found at these sites of S-acylation, this modification is usually referred to as palmitoylation.
Palmitoylation is a reversible and dynamic posttranslational modification; the cycle between a palmitoylated and depalmitoylated state of a protein has been estimated to vary between seconds and hours (6) (7) (8) (9) (10) . Palmitate is a 16-carbon saturated fatty acid that can be attached to proteins posttranslationally. This modification increases protein hydrophobicity, facilitates protein interactions with lipid bilayers, and can markedly alter the protein's sorting and function. Whereas other additions of fatty acid such as myristoylation and isoprenylation are stable and permanent lipid modifications, the thioester bond that links protein to palmitate is labile and reversible (11) . As such, conceptually it is similar to signaling processes mediated via phosphorylation and dephosphorylation. Palmitoylation has been shown to play an important role in the regulation of protein trafficking (12) , in particular in the nervous system (13) (reviews (11, (14) (15) (16) ). Palmitoylation is conducted by a group of DHHC (where the active site contains a tetrapeptide motif composed of aspartate-histidine-histidine-cysteine, DHHC) protein acyl-transferases (17) (18) (19) (20) (21) . Twenty-three palmitoylation enzymes are present in the mammalian proteome (17, 22) . Relatively less known are the depalmitoylation enzymes, which catalyze the removal of the palmitate group from palmitoylated proteins (review (10) ). Two serine hydrolases, LYPLA1 (lysophospholipase I) (23) and PPT1 (24) , have been shown to hydrolyze palmitoylated HRAS in vitro (Harvey Rat Sarcoma Viral Oncogene Homolog). However, in vivo activity has been demonstrated only for LYPLA1 (25, 26) . A proteomics screen has identified additional nineteen serine hydrolases, which have the potential to depalmitoylate protein substrates (27) .
Our study is focused on PPT1, which is mutated in individuals with CLN1. The PPT1 protein is produced in the endoplasmic reticulum, glycosylated, secreted and endocytosed. It reaches the lysosomes via the mannose-6-phosphate pathway (5, 28) . In neurons, PPT1 is found in the axon and in synaptosomes (29, 30) . In the absence of PPT1, the inability to degrade the thioester linkage leads to the accumulation of S-acylcysteine-containing peptides (31) . Disruption of the mouse Ppt1 gene results in a suitable mouse model for Infantile Neuronal Ceroid Lipofuscinosis (2, 32) . Several studies have indicated that ER stress plays a role in the neurodegenerative process manifested at the later and final stages of the disease (33) (34) (35) . Some neuronal abnormalities were noted to occur prior to synapse degeneration (36) , and it has been suggested that astrocyte activation is part of the pathophysiology of the disease (37) . Our experimental results have led us to investigate possible functions of PPT1 in cilia. The cilium contains a unique composition of proteins involved in sensory signaling, and defects in cilia formation and/or function are causative for a large group of heterogeneous disorders now known as ciliopathies (38) (39) (40) (41) . The ability of the cilia to organize signaling events stems from the tightly organized and dynamic spatial organization of proteins and lipids (42) (43) (44) . Entry of proteins into the cilia is governed by several rules; small molecules can enter in a passive manner whereas larger molecules require ciliary-targeting signals and an active transport pathway (42, 45) . Import of cytoplasmic molecules into the ciliary compartment utilizes molecules and mechanisms similar to those that regulate import into the nuclear compartment (46) (47) (48) (49) .
PPT1 is a depalmitoylation enzyme, thus mutations are likely to result in altered protein hydrophobicity and membrane localization. Therefore, we hypothesized that the protein content of membranes extracted from brains of mutant newborn mice (P1) enriched in acylated proteins would differ from those derived from wildtype mice. This analysis revealed that the majority of the proteins identified in this screen are palmitoylated and could be shown to be associated with neurodegenerative diseases by pathway analysis. One of the proteins that showed differential abundance in Ppt-/-versus wildtype membranes was Rab3IP, which is a direct downstream effector of Rab11 that affects the guanine nucleotide-exchange activity of Rab3IP towards Rab8. Rab3IP, Rab11 and Rab8 are essential for vesicular trafficking and are known to be involved in ciliogenesis. Our analysis showed that these three proteins are palmitoylated. Site-directed mutagenesis of the palmitoylation sites of Rab11 affected its intracellular localization. Longer cilia were detected in primary cells derived from Ppt1-/-mice; MEFs (mouse embryonic fibroblasts), neuroblasts and neurons as well as in brain preparations. Collectively, our results suggest that cilia abnormalities should be considered as part of the pathophysiology of CLN1.
Results
The composition of membrane proteins in brain differs in Ppt1-/-and wild type
Mutations in Ppt1 result in early onset neurodegeneration; therefore, we hypothesized that the levels of proteins extracted from purified brain membranes of newborn mice would differ prior to the appearance of the neurodegenerative phenotype. The hydrophobic index of proteins is greatly affected by their palmitoylation. Therefore, the palmitoylation status of a particular protein may affect its interaction with other proteins and with membranes. Assuming that PPT1 substrates are over palmitoylated in Ppt1-/-brains, it is possible that their localization to specific membrane domains are altered. Triton X-100 soluble (TS) membranes were isolated from five wild-type and five Ppt1-/-brains and proteins were identified by ABE (acyl-biotin exchange) chemistry (50) . Many of the identified proteins were found to be palmitoylated (Supplementary Material, Table S1 ). A list of 88 proteins was significantly over or under represented in the mutant and the WT membrane fractions (Supplementary Material, Table S1 ). Most of the TS proteins (58 or 66%) were less abundant in the KO. The direction of the change in three of the proteins was verified by Western blot analysis (Fig. 1A) . However, it should be noted that Western blot analysis is less quantitative than mass spectrometry (51, 52) . A significant proportion (78 or 88%) of the proteins identified in the screen were found to be palmitoylated based on our current study or on previous reports (50, (53) (54) (55) . This finding supports the notion that palmitoylated proteins are likely to be those that might change their association with membrane domains when a depalmitoylation enzyme is mutated. Common upstream molecules for 32 out of 88 proteins (36%) were identified using the Ingenuity software package. Interestingly, the upstream networks that the Ingenuity analysis identified are involved in well-known neurodegenerative diseases (Fig. 1B) . The most prominent networks include MAPT (tau), APP (amyloid precursor protein), and (PSEN1) Presenilin1, which are involved in the pathophysiology of Alzheimer's disease, and HTT (Huntingtin) that is mutated in patients with Huntington's disease, as well as additional neurodegenerative diseases. Our experimental design involved extraction of membrane-associated proteins from newborn mice, prior to the appearance of early signs of the neurodegenerative symptoms. These results thus extremely reveal in the light of the pathophysiology of the Neuronal Ceroid Lipofuscinosis, which manifests as an early onset neurodegenerative disease. The samples prepared from newborn asymptomatic mice, show the differential profile of membrane proteins many of which are players within neurodegeneration networks, and may predict predisposition for degeneration.
A bias towards cilia proteins
A second feature, which was noted is that many of the proteins (62 out of 88, 70%) differentially represented in membrane fractions are members of the cilia proteome ((56,57) and http://v3.ciliapro teome.org/cgi-bin/index.php), Supplementary Material, Table S1 ). One of the proteins whose association with membranes differed between genotypes is Rab3IP (also known as Rabin 8), with a fold change greater than nine. Rab GTPases, in particular Rab8 and Rab11, share the regulation of vesicular trafficking during primary ciliogenesis (58) (59) (60) (61) . Rab3IP is a direct downstream effector of Rab11, which in its GTP-bound form, interacts with Rab3IP and kinetically stimulates the guanine nucleotide-exchange activity of Rab3IP toward Rab8. Rab11 has been previously localized to the centrosome as well as in the base of the primary cilia and the inhibition of its function impaired primary ciliogenesis (59) .
Based on the above observations, we then tested whether PPT1 can be detected in the cilia. Immunostaining of mouse embryonic fibroblasts using antibodies against known cilia proteins and anti-PPT1 antibodies revealed co-localization. Anti-acetylated tubulin ( Fig. 2A, D , F, G) and anti-Rab3IP (Fig. 2C, E , F, G) immuno-stained cilia as expected, and part of the observed PPT1 immunostaining signal (Fig. 2B, D , E, G) was detected along the cilia. This localization has not been observed previously. Therefore, we raised the hypothesis that the composition of ciliary proteins may differ between wild-type and Ppt1-/-. Cilia were prepared from newborn dissociated brain cell cultures and were analyzed by MS Table S1 by Ingenuity software revealed that thirtytwo of the proteins are associated with neurodegenerative pathways.
(Supplementary Material, Table S2 ). Six hundred and sixty-one proteins were found to be differentially expressed by 1.5-fold change or greater in cilia prepared from the two genotypes. This result suggests that in cells lacking PPT1, cilia formation and/or function may be affected. Taking into consideration the pivotal roles of Rab3IP, Rab8 and Rab11 in primary ciliogenesis, we tested whether these proteins are undergoing palmitoylation.
Rab3IP, Rab8 and Rab11 are palmitoylated proteins
The possibility that Rab3IP can be modified by the attachment of a palmitate group was examined by co-transfecting GFPtagged Rab3IP with a repertoire of twenty-three HA-tagged palmitoylation enzymes (Fig. 3A) . We used metabolic labeling of transfected HEK293 cells with the commercial alkynyl fatty acid analogue 17-octadecynoic acid (17-ODYA) (62) . The cellular palmitoylation machinery readily incorporates 17-ODYA into endogenous sites of palmitoylation within the native cellular environment. After sufficient labeling, the cells are lysed, and following immunoprecipitation with anti-GFP antibodies, the proteins were then coupled with azide-linked reporter tag by Cu(I) catalyzed click chemistry. Palmitoylated proteins are easily detected after rhodamine-azide conjugation for fluorescent gel-based analysis, which reveals palmitoylation (Fig. 3A upper  panel) . HEK293 cells contain endogenous DHHC enzymes, and some endogenous palmitoylation of GFP-Rab3IP can be detected in the mock control transfected cells (-lane). The experiment demonstrates that Rab3IP is palmitoylated by both DHHC3 and DHHC7. In addition, normalization and quantification of this and an additional experiment suggest that DHHC5, 9, 12, 13, 14, 15, 23, and 24 may palmitoylate Rab3IP (Supplementary Material, Table S3A ). To further verify that the observed protein modification is indeed palmitoylation and not other irreversible fatty acid modification, the above-described experiment was repeated with one of the identified enzymes, DHHC3 (Fig. 3B) . The sample was treated with neutral hydroxylamine to selectively cleave thioesters (62) . The palmitoylation signal seen on Rab3IP was markedly reduced thus suggesting that the observed signal was due to palmitoylation (Fig. 3B) . The relative normalized value of Rab3IP across experiments was 41.54 6 12.5, while the relative normalized value of reduced Rab3IP signal across experiments was 6.08 6 4.42; these differences are statistically significant (Student's t-test, P ¼ 0.028).
Similarly, the palmitoylation of Rab11 was tested using the same metabolic labeling method described earlier (Fig. 3C ). Like Rab3IP, the gel scan detecting 17-ODYA labeling revealed that Rab11 is palmitoylated by the same enzymes, DHHC3 and DHHC7 ( Fig. 3C upper panel) . In addition, normalization and quantification of this and an additional experiment suggest that DHHC5, 9, 12, 13, 14, 15, 23, and 24 may palmitoylate Rab11 (Supplementary Material, Table S3B ). Addition of neutral pH hydroxylamine reduced the palmitoylation signal observed in the presence of DHHC3, suggesting a reversible modification (Fig.  3D) . The relative normalized value of Rab11 across experiments was 44.95 6 4.24, while the relative normalized value of reduced Rab11 signal across experiments was 13.57 6 3.27; these differences are statistically significant (Student's t-test, P ¼ 0.0009). To identify the enzyme that removes the palmitate from Rab3IP and Rab11 the activity of three depalmitoylation enzymes was tested PPT1, or LYPLA1 or LYPLA2 (Fig. 4) . Rab3IP (Fig. 4A) or Rab11 ( Fig. 4B ) palmitoylation signal was partially reduced following the addition of either LYPLA1 or LYPLA2. However, no signal reduction was observed after incubation with PPT1, which was therefore unable to reverse Rab3IP palmitoylation.
Rab8, was found to undergo palmitoylation by multiple DHHC enzymes (data not shown). The palmitoylation of Rab8 by DHHC2 was sensitive to hydroxylamine treatment (Fig. 5A) . Then, the possibility that Rab8 and Rab11 are palmitoylated proteins in vivo was examined. The palmitoylation of Rab8 and Rab11 was examined in mouse embryonic brains (Fig. 5B) . The neuroblasts were metabolically labeled by in utero injection of 17-ODYA into the brain ventricles, combined with in utero electroporation of a GFP expression plasmid. After 20 h, the brains were dissected subjected to immunoprecipitation with antiRab8 or anti-Rab11 antibodies and subjected to click chemistry. Half of the samples were treated with neutral hydroxylamine. The scanned image of the gel with 17-ODYA labeling and the blots indicate that Rab8 and Rab11 are palmitoylated in the developing brain. In addition, IMCD3 cells were metabolically labeled, Rab8 or Rab11 were subjected to immunoprecipitation, followed by click chemistry and hydroxylamine treatment (Fig. 5C ). The palmitoylation of Rab8 and Rab11 is noted in IMCD3 cells too. Collectively, our studies demonstrate that Rab3IP, Rab11 and Rab8 are palmitoylated proteins. Rab3IP and Rab11 are palmitoylated by DHHC3 and DHHC7 and are depalmitoylated by LYPLA1 or LYPLA2 but not by PPT1.
Palmitoylation of Rab11 affects its intracellular localization
To gain further insights on how palmitoylation may affect the intracellular localization and activity of Rab11, several GFPtagged Rab11 constructs were expressed in NIH3T3 cells (Fig. 6 ). Wild-type Rab11 localizes to the basal body at the feet of the primary cilium, as previously reported (58) (Fig. 6A) . Its localization to the centrosome was confirmed by colocalization with cTubulin ( Fig. 6 D and E) . A centrosomal localization of a constitutively active Rab11 (Rab11 CA, Q70L) was also observed (Fig. 6B) , however, the dominant-negative Rab11 (Rab11 DN, S25N) exhibited a predominant nuclear localization in addition to a diffuse cytoplasmic pattern (Fig. 6C ). Rab11 contains only two cysteine residues. We chose to mutate these residues since they were recognized as potential target of palmitate attachment. To examine whether these mutations impair Rab11 palmitoylation, cells were transfected with different GFP-tagged Rab11 expression constructs and HA-tagged DHHC3, and metabolically labeled as described above. The image of the scanned gel showing 17-ODYA labeling revealed that mutations in either C223 or C224 resulted in reduction of palmitoylation while the non-mutated protein was modified by DHHC3 ( Fig. 6F upper panel) . The average normalized palmitoylation level of Rab11 across experiments was 44.95 6 4.4 (n ¼ 7) versus the average normalized level of the mutants 9.72 6 3.0 (n ¼ 6). The difference was statistically significant P < 0.0001, Student's t-test. Interestingly, Rab11 mutated in either cysteine residues, C223S or C224S, showed nuclear localization similar to that seen with dominantnegative Rab11 (Fig. 6G, H, respectively) . Collectively, our results suggest that Rab11 is palmitoylated on C223 and C224 and mutations in either of these sites affect its intracellular localization. These findings imply that in the absence of Rab11 palmitoylation, proper intracellular localization cannot be achieved and Rab11 ciliary activities are likely to be affected.
Cilia in Ppt1-/-are abnormal
The changes in the activities of Rab11, Rab8 and Rab3IP raised the hypothesis that cilia abnormalities may exist in Ppt1-/-mice. One of the striking features of cilia is their length. Deviation from the optimal length, either too short or too long, results in improper activity and signaling (63,64)(review (44)). Primary cilia of fibroblasts from Ppt1-/-mice were 43% longer than the cilia from wild type (2.47 60.1 mm versus 1.726 0.95 mm, n ¼ 95, 131; Ppt1-/-and wildtype, respectively, Student's t test, P-value¼ 8.12Â10 À11 ) ( Fig. 7A versus B) . Scanning EM images also showed that the structures of cilia in MEFs derived from Ppt1-/-mice were normal but somewhat longer in comparison with those derived from wildtype (Supplementary Material, Fig.  S1A ,B,E,F). We postulated that in mutant cilia, the transport of proteins along the cilia may be affected. Therefore, we examined the localization of acetylated-tubulin and Rab3IP along the cilia in wild type and Ppt1-/-MEFs ( Fig. 7C-H) . The absence of PPT1 affected the distribution of both proteins along the length of the cilia, which is suggestive of a transport defect. Although as mentioned above, Ppt1-/-cells exhibited longer cilia, less acetylated tubulin and less Rab3IP occupied the distal part of the cilia regardless of the cilia length (Fig. 7I versus J) . The changes in the distribution of acetylated tubulin were not coupled with changes in the total protein amount. The levels of Rab3IP however were decreased by an approximate two fold in the cilia of Ppt1-/-as estimated by immunohistochemistry. (arrows, upper panels). Equivalent amounts of GFP-Rab3IP and Rab11 were immunoprecipitated (A,B arrow IP blotted with anti-GFP). Western blot analysis revealed similar expression levels of HA-DHHC3 and GFP-Rab11 throughout the experiment, using anti-HA antibodies (arrow anti-HA), and the expression of PPT1. The expression of LYPLA1 and LYPLA2 was confirmed using specific antibodies (lower panels).
We then proceeded to examine the cilia of neurospheres derived from Ppt1-/-and wild type mice. Primary cilia of neurospheres from Ppt1-/-mice were 43% longer than the cilia from wild type (2.26 60.083 mm versus 1.58 6 0.066 mm, n ¼ 93, 97; Ppt1-/-and wildtype, respectively, Student's t test, P-value¼ 8.44Â10 À10 ) ( Fig. 7K and L) . In addition, the relative ratio of ciliated cells differed, whereas 66% of the wild type neurosphere cells were ciliated, only 46% of the mutant neurosphere cells bore cilia. It should be noted that there is a strong link between the cell cycle progression and the primary cilium cycle. Thus, assessment of cilia length and number in neurospheres may be compromised by the existence of putative cell cycle progression defects. Nevertheless, we did not observe obvious differences in the growth rate or the sizes of the neurospheres. A three-fold difference in cilia length was noted in primary hippocampal neurons derived from Ppt -/-and control littermates ( Fig. 7M  and N) . Primary cilia from Ppt1-/-mice were 4.75 6 0.4 mm long in comparison with 1.55 6 0.19 mm long cilia measured in the wild type cells (n ¼ 29,31, respectively, Student's t test,
). In whole mount brain preparations from mutant and wild type embryos (E17), similar differences were noted including increased cilia length reduced recurrence of ciliated cells ( Fig. 7O and P) . The overall morphology of cilia in the hippocampus as examined by TEM (transmission electron microscopy) did not differ (Supplementary Material, Fig.  S1C,D,G,H) .
More importantly, we examined cilia in the retina, which is an organ affected by the disease (Fig. 8) . Here, the localization and observed immunostaining of two proteins, which were identified in our proteomics studies, Kif27 and Rab3IP were carefully evaluated. Kif27 is a member of the mammalian microtubule associate molecular motor kinesin family of proteins. Our MS analysis indicated that the levels of this protein are reduced in Ppt1-/-cilia preparations (Supplementary Material, Table S2 ). These findings are reflected in immunostaining of retina preparations, where more immunoreactivity is observed in the sections from control mice (Fig. 8A and B) . Furthermore, whereas within wildtype cilia Kif27 is found close to the basal body and in the axoneme, in cilia derived from mutant mice the protein is detected only close to the base (Fig. 8C,C' versus D,D' ). In case of Rab3IP, more immunoreactivity was observed in sections from Ppt1-/-retinas ( Fig. 8F versus E). Rab3IP is typically detected in the tips of wildtype cilia, but in mutant cilia it can be detected along the entire length (Fig. 8G, G' versus H,H' ). Collectively, our findings indicate that ciliopathy is likely to be part of the pathology of PPT1 deficiency.
Discussion
Infantile neuronal ceroid lipofuscinosis patients are asymptomatic at birth and are considered to develop normally until they experience seizures, blindness, cognitive impairment, motor dysfunction and a short life span (65) (66) (67) (68) . A suitable mouse model was generated by disruption of the CLN1 gene. These mice lack the expression of PPT1 and exhibit the hallmarks of the disease (2, 37, (69) (70) (71) . Infantile CLN1 has an early onset with symptoms appearing as early as 18 months in affected individuals. The mouse model of infantile CLN1 disease, used in this study has no PPT1 activity. These animals are considered a valuable model as they recapitulate many features of the human disease; neurodegeneration, brain atrophy and cortical thinning, auto-fluorescent accumulation, retinal dysfunction, as well as seizures, motor deficits and shortened lifespan (2) . Interestingly, despite the progressive nature of the symptoms, an assessment of 3-6-month-old Ppt1 knockout mice and their normal littermates suggests that the phenotype appears earlier than previously estimated (72) . This is consistent with the presymptomatic changes in the membrane localization of substantial number of ciliary proteins in the neonate Ppt1 knockout mice. The primary cilium is a microtubule-based extension of the cell membrane, which is found in nearly all cell types. The study of the neuronal phenotype of ciliopathies such as Joubert and related syndromes suggests that cilial function is required for some aspects of neuronal development within the cerebral cortex through as of yet unknown mechanisms (73, 74) . Recently, thirty cilia related genes were studied in an in utero electroporation based approach that revealed their involvement in multiple steps during corticogenesis including progenitor proliferation, neuronal polarization, glial-guided migration and axogenesis (75) . Ciliopathies ares a collection of conditions with variable symptoms grouped by a common mechanism-ciliary malfunction. It's therefore hard to pinpoint phenotypes as being indicators of a cilia related pathology. Nevertheless, retinal involvement leading to blindness seems to appear in Ppt1 knockout mice as well as a phenotype common to several ciliopathies (76) . Most studies have been conducted in mice when signs of neurodegeneration are visible. To gain insights on presymptomatic changes we have used an unbiased proteomics approach to scan for possible differences in the composition of membrane proteins in the brains of neonate mice. A novel list of 88 proteins differentially represented in a membrane preparation was derived, with most of them being palmitoylated proteins. This finding is not unexpected taking into consideration that PPT1 is a depalmitoylation enzyme, and dual fatty acid modifications will affect protein-membrane integration. The changes identified obviously include both direct substrates for PPT1 and proteins indirectly affected by PPT1 deficiency. Ingenuity upstream pathway analysis revealed that many of the detected proteins are linked to neurodegenerative pathways. Thus, even at this very early stage, it is possible to detect disease biomarkers. In a previous study, two proteins (VDAC1 and Pttg1) whose expression level changed at a late symptomatic stage, were found to differ also at an early presymptomatic stage in two different neuronal ceroid lipofuscinoses disease models (77) . Another study indicated an early change in the systemic lipid homeostasis of Ppt1 deficient mice, and emphasized a novel role for PPT1 in the regulation of lipoprotein metabolism (78) .
Unexpectedly, many of the abundant membrane proteins that were previously found to belong to the cilia proteome were expressed in the absence of PPT1. The primary cilium is a specialized sensory organelle that protrudes from the surface of nearly all cells in the body. Defects in cilia formation and/or function are causative for a large group of heterogeneous disorders now known as the ciliopathies (38) (39) (40) (41) . Our findings suggest a novel link between palmitoylated proteins and cilia. Furthermore, we demonstrated that proteins that are key for ciliogenesis and for vesicular transport to the primary cilium, Rab8, Rab11 and Rab3IP (42) , are palmitoylated. Our results suggest that palmitoylation of Rab11 may affect the activity and the intracellular localization of Rab11. A novel route for transport of membrane proteins into cilia has been proposed for the Hedgehog signaling factor Smoothened. Smoothened may be transported laterally from the plasma membrane into the ciliary membrane (79, 80) . Work in trypanosomes has shown that palmitoylation regulates the targeting of a ciliary protein and that the ciliary membrane is enriched in lipid raft components (81,82) (review (83)). Our findings suggest that palmitoylation may affect the targeting of some proteins to the cilia and may further affect intra-ciliary transport.
Our findings suggest that infantile neuronal ceroid lipofuscinosis could be considered as a ciliopathy. We detected a previously unrecognized localization of the PPT1 protein to the cilia. In the absence of PPT1, elevated levels of Rab3IP were detected in brain membranes; however, within cilia, the amount of Rab3IP was reduced and it was less evenly distributed along the length of the cilia. The proteome composition of cilia lacking PPT1 differed from wild type cilia. The functional effects of the absence of PPT1 on cilia length and on key proteins regulating the cilia suggest the inclusion of infantile neuronal ceroid lipofuscinosis in the ciliopathies as an expansion of current networks (84, 85) . The key features of infantile neuronal ceroid lipofuscinosis include retinal degeneration (86, 87) and intellectual impairment that are part of the pathophysiology of ciliopathies (40) . Importantly, the localization of Kif27 and Rab3IP was abnormal in retinal cilia. Collectively, these data implicate infantile neuronal ceroid lipofuscinosis as a ciliopathy.
Materials and Methods

Mice
Mice mutated for Ppt1 were previously published (2) and were obtained from Jackson laboratories, each mouse was genotyped using the primers recommended by Jackson (http://www.jax. org/about/index.html). The breeding strategy was heterozygote mating, to avoid a selection bias in the genotype. In utero electroporation was conducted as previously described (88) . All animal procedures were approved by the Weizmann Institute IACUC. 
Cells
Cortical cultures were prepared from neonatal (P2) brains of Ppt1þ/þ or Ppt1-/-mice. Briefly, cortices were dissected in Oxygenated ice-cold Leibovitz's L-15 medium supplemented with 6% glucose and Gentamycin. After the removal of meninges, the cortices were dissociated mechanically and plated on poly-l-lysine/laminin coated cover glass. Cultures were grown kept in Neurobasal medium (Neurobasal, supplemented with 1% B-27, 1% N2, 2 mM glutamax, 0.6% glucose and gentamycin). Mouse Embryonic Fibroblasts (MEFs), were prepared from E14.5 to 15.5 trunks. Embryos were dissected, washed in PBS and later incubated in 0.05% trypsin-EDTA for 10 min, at room temperature. The process was repeated twice with gradually shorter incubation times (5 min). The resulting cell suspension was pooled, and washed once with PBS. Cell were re-suspended in MEF medium (DMEM, 10% Fetal calf serum (FCS), 0.2% penicillin -streptomycin). To induce formation of cilia, cultures were serum starved (DMEM, 0.5% FCS) for 48-72 h. Neurospheres were prepared from E14-15 embryos cortices. The cortices were dissected, as describe and washed with PBS. Cells were dissociated mechanically, pelleted and resuspended and plated in neurosphere medium (Neurobasal media, supplemented with 2% B-27, 2 mM glutamax, 0.2% penicillin-streptomycin, 20 ng/ml EGF, 20ng/ml bFGF, 2 lg/ml Heparin). Hippocampal neurons were prepared from E18 embryonic brains. Hippocampi were dissected into L15 dissecting media as described. Cells were dissociated mechanically and plated in MEM medium supplemented with, 0.6% Glucose, 2 mM Glutamax, 0.1% B-27, 5% FCS, 5% Horse Serum (HS), and Gentamycin). After four days glial cell growth was inhibited by 5-Fluoro-2 0 -deoxyuridine (FUDR),
Glutamax, 10% HS, Gentamycin, 20 lm FUDR 20 lm Uridine). For all primary cultures tails were taken for genotyping. NIH3T3 and HEK293 were cultured in DMEM supplemented with 10% FCS, 2 mM L-glutamine and penicillin-streptomycin. NIH3T3 were transfected with LipofectamineV R 2000 reagent (life technologies, 11668019), HEK293 were transfected with Calcium-Phosphate.
Plasmids
DHHC enzymes were kindly provided by Prof. Masaki Fukata (17,7), pEGFP-Rab8 and pEGFP-Rab3IP were kindly given by Dr. Johan Peranen (59), pEGFP-Rab11A from Prof. Alexander Bershadsky. Human PPT1 was kindly provided by Dr. Sandra L. Hoffmann and sub-cloned into a pCAGGS expression vector. Depalmitoylation enzymes, LYPLA1 (lysophospholipase I) and LYPLA2 (lysophospholipase II) were sub-cloned from RIKEN clones AK002674 and AK075590, respectively, into pCAGGS mammalian expression vectors.
Antibodies
Anti-GFP (Roche, 11 814 460 001), Anti-HA (mouse hybridoma 12CAS), Anti-Acetylated tubulin (Clone 6-11B-1, T6793, Sigma), Anti-gamma tubulin (Clone GTU-88, Sigma), Anti-A cyclase III (C-20, sc-588, Santa Cruz Biotechnology INC.), Anti-Rab3IP (S-14, sn-162069, Santa Cruz Biotechnology Inc.). PPT1, LYPLA1 and LYPLA2 antibodies were generated by injection of 6xHis purified recombinant proteins to Rabbits at the Weizmann Institute of Science. Validation of PPT1 antibodies has been shown (manuscript in press).
Preparation of retina
Enucleated eyes of P50 adult mice were mounted in Tissue-Tek (O.C.T), and were frozen in liquid nitrogen. Blocks containing both wildtype and knockout eyes were cryo-sectioned in 10 lm thick slices. The sections were dried, then rehydrated in PBS and fixed for 10 min using 4% formaldehyde. After phosphatebuffered saline (PBS) wash, retinal sections were permeabilized with 0.1% Triton X-100 PBS (PBS-T) and blocked by incubation with blocking solution (10% horse serum 10% Fetal calf serum in PBS-T) for 0.5 h at room temperature. Retinal sections were incubated for 2 h in primary antibodies, washed three times with PBS-T and incubated with secondary antibodies for additional 30 min, washed again and mounted using Molecular Probes Prolong Gold antifade mountant with DAPI.
Preparation of triton X-100 soluble (TS) fractions for detection of protein palmitoylation by mass spectrometry
Palmitoylated membranal proteins were isolated as described previously (50) . Briefly, brains for neonatal mice (P1-P2) were collected and washed in PBS three times. Brains were homogenized and nuclei were pelleted at 500g for 5 min. Membranes were pelleted at 16,000g for 20 min. Membrane pellets were resuspended in buffer A (25 mM 2-(N-morpholino)-ethanesulfonic acid, 150 mM NaCl, pH 6.5) and then the same volume of buffer A complemented with 2% Triton X-100 and phosphatase and protease inhibitors was added. Membranes were incubated 60 min on ice and centrifuge 16,000g for 20 min at 4 C. The supernatants (Triton X-100 soluble fractions) were used in ABE reactions to identify palmitoylated proteins by mass spectrometry.
ABE chemistry for detection of palmitoylation in PPT1 knockout and wild type mice Acyl-Biotinyl Exchange chemistry (ABE) was performed as described previously (21,89) with some minor modifications. Protein concentrations of the Triton X-100 soluble (TS) fractions of brain cells from five PPT1 knockout and five wild type mice were determined using the micro-Lowry protein assay kit (Sigma-Aldrich, St. Louis, MO, USA) according to the manufacturer's instructions. 300 mg from each TS fraction was precipitated using the chloroform-methanol (CM) method. Precipitated protein pellets were re-solubilized in 25 ml 4% SDS buffer (50 mM Tris-HCl pH 7.4, 4% SDS, 5 mM EDTA) at 37 C for 15 min followed by incubation in a sonication bath for 2 min. The samples were diluted with three volumes of dilution buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM EDTA, 0.2% Triton X-100 supplemented with EDTA free protease inhibitor cocktail (Roche Diagnostics, Mannheim, Germany) and reduced with 10 mM TCEP (tris(2-carboxyethyl)phosphine) at 56 C for 30 min followed by alkylation with 50 mM NEM (N-ethylmaleimide) for 2.5 h at room temperature with end-over-end rotation. Four sequential CM precipitations were performed to remove excess NEM. In between each precipitation the pellets were re-dissolved in 25 ml 4% SDS buffer at 37 C for 15 min followed by incubation in a sonication bath for 2 min and diluted with three volumes of dilution buffer. After the fourth precipitation the samples were stored at À20 C. The next day a fifth CM precipitation was performed and the protein pellets were re-solubilized in 50 ll 4% SDS buffer and divided equally into two portions (experimental HAþ portion, and control HA-portion, respectively). Three volumes of a freshly prepared solution of 0.53 mM N-[6-(biotinamido) hexyl]-3-(2-pyridylthio) propionamide) (biotin-HPDP), 0.27% Triton X-100 13.2% N,N-di-methylformamide supplemented with EDTA free protease inhibitor cocktail, pH 7.4 was added to each portion. For the experimental HAþ portions the solution contained 1M hydroxylamine (HA) pH 7.4 whereas for the control HA-portions the HA was substituted with 50 mM Tris-HCl pH 7.4. Samples were incubated for 1.5 h at room temperature with end-over-end rotation. Excess of biotin-HPDP was removed by two sequential CM precipitations. In between the precipitations the samples were re-dissolved in 25 ml 4% SDS buffer at 37 C for 15 min followed by incubation in a sonication bath for 2 min and diluted with three volumes of dilution buffer. After the second precipitation the samples were stored at À20 C. The next day a third CM precipitation was performed and the protein pellets were re-solubilized in 12.5 ll 2% SDS buffer (50 mM Tris-HCl pH 7.4, 2% SDS, 5 mM EDTA). The samples were diluted with 19 volumes of dilution buffer, incubated for 30 min at room temperature with end-over-end rotation followed by centrifugation for 10 min at 16,000g to remove any particulates. The samples were transferred to new micro-centrifuge tubes containing 25 ll pre-equilibrated avidin agarose beads (Pierce Biotechnology, Rockford, IL, USA) and incubated for 1.5 h at room temperature with end-over-end rotation. The beads were successively washed five times for 2 min with 50 volumes of equilibration buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM EDTA, 0.2% Triton X-100, 0.1% SDS). The beads were pelleted by centrifugation at 200g for 2 min in between each wash step. The proteins were eluted by incubating the beads with 250 ll 20mM TCEP in equilibration buffer for 30 min at room temperature with endover-end rotation followed by centrifugation at 200g for 2 min. The supernatants were centrifuged again at 200g for 2 min and transferred to new microcentrifuge tubes. The proteins were concentrated by a CM precipitation and re-dissolved in 20 ll 2% SDS buffer. After the addition of 20 ll Laemmli buffer the proteins were resolved by 12.5% Criterion precast TGX gels (BioRad, Hercules, CA, USA) and silver stained as described by Schevchenko et al. (90) . Each lane was excised and divided into smaller pieces (2Â2 mm) and in-gel digested essentially as described (91) . Briefly, the gel pieces were washed repeatedly in 50% acetonitrile in 50 mM ammonium bicarbonate and 100 mM ammonium bicarbonate and then dehydrated in 100% acetonitrile and dried in a vacuum centrifuge. The disulfide bonds were reduced with 10 mM TCEP in 100 mM ammonium bicarbonate for 1 h at 56 C, followed by alkylation with 55 mM iodoacetamide in 100 mM ammonium bicarbonate for 45 min at room temperature in the dark. After washing with 50% acetonitrile in 50 mM ammonium bicarbonate the gel pieces were dehydrated in 100% acetonitrile and dried in a vacuum centrifuge. The gel pieces were rehydrated on ice for 45 min in digestion buffer containing 10 ng/ll sequencing-grade modified trypsin in 50 mM ammonium bicarbonate and then incubated at 37 C overnight. Peptides were successively extracted three times with 5% formic acid in 50% acetonitrile for 30 min. Samples were dried down in a vacuum centrifuge and cleaned up using Stage-Tip C18 columns (Proxeon Biosystems, Odense, Denmark) according to the manufacturer's instructions. The eluted peptides were dried in a vacuum centrifuge, dissolved in 0.1% formic acid, and stored at À20 C until analysis by nanoflow reversed phase HPLC tandem mass spectrometry.
Mass spectrometry
An ESI-LTQ-Orbitrap XL mass spectrometer (Thermo, Bremen, Germany) interfaced with an Eksigent 2D NanoLC system (Eksigent Technologies, Dublin, CA, USA) was used to analyze the peptides derived from in-gel digestions after ABE chemistry.
Peptides were loaded at a constant flow rate of 10 ll/min onto a pre-column (Acclaim PepMap 100, C18, 5 lm, 5 mm x 0.3 mm, Thermo Fischer Scientific, H€ agersten, Sweden) and subsequently separated on a 10 lm fused silica emitter, 75 lm x 16 cm (PicoTip Emitter, New Objective, Inc. Woburn, MA) packed inhouse with Reprosil-Pur C18-AQ resin (3 lm Dr. Maisch GmbH). Peptides were eluted with a 60 min linear gradient of 3% to 35% acetonitrile in water, with a flow rate of 300 nl/min. The LTQOrbitrap was operated in a data-dependent mode, simultaneously acquiring MS spectra in the Orbitrap (from m/z 400 to 2000) and MS/MS spectra in the LTQ. Four MS/MS spectra were acquired using collision-induced dissociation (CID) in the LTQ. The normalized collision energy was set to 35%. Each Orbitrap-MS scan was acquired at 60,000 FWHM nominal resolution settings using the lock mass option (m/z 445.120025) for internal calibration. The dynamic exclusion list was restricted to 500 entries using a repeat count of two with a repeat duration of 20 s, and with a maximum retention period of 120 s. Precursor ion charge state screening was enabled to select for ions with at least two charges and rejecting ions with the undetermined charge state.
Protein identification, quantification and detection of palmitoylation
Raw mass spectrometric data files were analyzed in the The Progenesis software was used both as a tool for the differential protein analysis between the knockout PPT1 and wild type mice and for the detection of palmitoylated proteins in the samples. For the differential protein analyses the experimental HAþ raw data files were compared between the knockout and wild type samples, whereas for the detection of palmitoylated proteins the paired experimental HAþ and control HA-raw data files were compared for each sample.
Preparation of cilia from cortical cultures for mass spectrometry
Cilia were isolated as previously described (92) . Briefly, cortical cultures were made from neonatal (P1-P2) Ppt1þ/þ and Ppt1-/-mice and grown on plates covered with poly-D-Lysine for 4-5 days. Cells were washed with PBS without calcium and then collected with a high calcium buffer (112 mM NaCl, 3.4 mM KCl, 10 mM CaCl2, 2.4 mM NaHCO3, 2 mM HEPES, pH 7.0). Cells were rotated at 4 C for 10 min followed by centrifugation at 7,700g for 10 min. The supernatant was loaded on top of 45% sucrose solution in the high calcium buffer and centrifuged for 1 h at 100,000g. The sucrose-supernatant interface band was collected and diluted (1:10) in the high calcium buffer and centrifuged again for 1 h at 100,000g. The pellet was re-suspended in normal saline solution, pH 7.0, supplemented with 2.0 mM EGTA and 0.5 mM sucrose. Equal amounts of proteins from isolated cilia from each of two PPT1 knockout and two PPT1 wild type mice were resolved by 12.5% Criterion precast TGX gels and stained using Gel Code Blue Stain Reagent. Each of the four lanes was cut into 10 slices, in-gel digested with trypsin and analysed by nanoflow reversed phase mass spectrometry in the same way as described for the TS fractions. Protein quantitation and identification were also performed as described for the TS fractions using the Progenesis software and the same Mascot search database. Carbamidomethyl (Cys) was selected as fixed modification and oxidation (Met) as variable modification.
Cells for OMX imaging
MEFs produced from Ppt1þ/þ and Ppt1-/-mice were plated on coverslips and processed as described below for immunostaining. nPG (n-propyl gallate) Antifade Mounting Media was used for mounting step. The slides with coverslips were analyzed using DeltaVision OMXV R super-resolution imaging system in the GE (Applied Precision) R&D Facility in Issaquah, WA, USA.
Cells for wide field microscopy imaging
Cells were plated in 6-well dishes on coverslips and serum starved for 18h. The cells were fixed with 3% PFA and permealized for 4 min at À20 C with 100% methanol, blocked in PBS with 0.1% BSA, and immunostained with anti-acetylated tubulin, rabbit anti-PPT1 and goat anti-Rab3IP. For Rab11 immunostaining, cells were fixed with 10% trichloroacetic acid (TCA) on ice for 15 min. The cells were then fixed in 3% PFA with 4% sucrose for 10 min.
Cilia measurements
MEFs produced from Ppt1þ/þ and Ppt1-/-mice were enriched for cilia and immunostained with anti-acetylated tubulin, anti-PPT1 and anti Rab3IP. Cilia length was measured using ImageJ based on acetylated tubulin expression. The Rab3IP expression pattern along the cilia was measured using the Plot Profile tool in ImageJ providing intensities from cilia base to tip.
Metabolic labeling, click chemistry
Transfected HEK293 cells were grown as described above. Metabolic labeling and Click chemistry were performed as previously described (53, 93, 94) . Briefly, 17-octadecynoic acid (17-ODYA) (BioMol, Plymouth Meeting, PA, USA) was dissolved in DMSO (25 mM stock), was 1000 fold diluted in media, sonicated, and added to a confluent 10 cm plate of cells overnight. Following metabolic labeling, cells were harvested, washed once with ice-cold phosphate buffered saline (PBS) and pelleted at 1000g for 5 min. Cells were directly lysed in IP buffer; 0.2 ml 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 5mM EDTA, 1% Triton X-100 (Sigma, Rehovot, Israel) plus protease inhibitors and then incubated for 30 min on ice. Cell lysates were collected after centrifuging at 15000g for 15 min at 4 C to remove cell debris. A sample was taken for lysate control. The inspected proteins were immunoprecipitated as described above using the appropriate antibodies. The immunoprecipitated proteins were reacted with 40 ll freshly premixed click chemistry reaction cocktail Alexa FlourV R 647 azide or Tetramethylrhodamine azide (Invitrogen, Carlsbad, CA, USA) (100 lM, 10 mM stock solution in DMSO), tris(2-carboxyethyl) phosphine hydrochloride (TCEP) (1 mM, 50 mM freshly prepared stock solution in deionized water), tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl methyl] amine (TBTA) (100mM, 1.7 mM stock solution in DMSO) and CuSO4 Á5H2O (1 mM, 50 mM freshly prepared stock solution in deionized water) in PBS for 1 h at room temperature. The reactions were terminated by the addition of 10 ll 5Â reducing SDS-loading buffer with a low concentration of DTT (40% glycerol, 200 mM Tris-HCl pH 6.8, 8% SDS, 0.4% bromophenol blue, 20 mM DTT) and heated for 5 min at 95 C; samples were then loaded onto and separated by SDS-PAGE (8, 10 or 12% PAGE gel). Gels were scanned using an Amersham Biosciences Typhoon 9400 variable mode imager (excitation 633 nm, emission 670 nm filters) and then gels were immunoblotted and analyzed with specific antibodies.
Hydroxylamine treatment of samples
Hydroxylamine treatment was done by addition of 1M freshlymade hydroxylamine solution in the SDS-loading buffer.
Hydroxylamine was prepared as a 10M stock solution in PBS and the pH was adjusted to 7.4 using HCl.
Cortical slices preparation and staining
For cilia staining, the brains were dissected along the interhemispheric fissure. The hippocampus and overhanging cortex and thalamus were removed in order to expose the lateral ventricle. The whole mounts were fixed by immersion in 4% PFA overnight. Immunostaining was done in PBS containing 0.1% Triton X-100, 10% fetal or horse serum. The stained whole mounts were placed on a coverslip in an aqueous mounting solution and visualized using wide-field microscopy.
Supplementary Material
Supplementary Material is available at HMG online. 
